IMMUNEERING CORPORATION

Insiders Immuneering Corporation

Equities

IMRX

US45254E1073

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
1.59 ^USD	+9.66%		-3.64%	-78.37%

May. 07	Immuneering Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 09	Immuneering Corporation Presents Preclinical Data At the American Association for Cancer Research Annual Meeting	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Immuneering Corporation Appoints Thomas J. Schall to Its Board of Directors	Mar. 12	CI
Immuneering Corporation Appoints Mallory Morales as Chief Accounting Officer, Effective July 1, 2023	23-06-14	CI
Immuneering Appoints Harold E. Brakewood as Chief Business Officer	23-03-28	CI
Immuneering Corporation Appoints Leah R. Neufeld as Chief People Officer	22-10-20	CI
Immuneering Corporation Announces Committee Changes	22-09-19	CI
Immuneering Corporation Announces Executive Changes	22-07-25	CI
Immuneering Strengthens Board of Directors with the Appointment of Diana F. Hausman, M.D	22-01-18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW